1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
8091SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8096SP |
Drugs of Abuse Screen (10 Panel), Serum/Plasma |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8101SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9261SP |
Scopolamine Screen, Serum/Plasma |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |